Can you interpret the following labs: alanine aminotransferase 31 U/L, white blood cell count 3.4 ×10⁹/L, red blood cell count 2.04 ×10¹²/L, hemoglobin 8 g/dL, hematocrit 23.6 %, mean corpuscular volume 115.7 fL, mean corpuscular hemoglobin 39.2 pg, red cell distribution width 17.1 %, and platelet count 247 ×10⁹/L?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Severe Macrocytic Anemia with Leukopenia Requiring Urgent Workup for Vitamin B12/Folate Deficiency or Bone Marrow Failure

You have severe macrocytic anemia (MCV 115.7 fL, hemoglobin 8 g/dL) with leukopenia (WBC 3.4), which demands immediate investigation for vitamin B12 deficiency, folate deficiency, or bone marrow failure syndromes like aplastic anemia or myelodysplastic syndrome.

Critical Abnormalities Identified

Your labs show a constellation of concerning findings:

Red Blood Cell Abnormalities

  • Severe anemia: Hemoglobin 8 g/dL and hematocrit 23.6% (both critically low)
  • Marked macrocytosis: MCV 115.7 fL is significantly elevated (normal ~80-100 fL)
  • Low RBC count: 2.04 ×10¹²/L indicates severely reduced red cell production
  • Elevated RDW: 17.1% suggests heterogeneous red cell population, indicating active but disordered erythropoiesis 1

White Blood Cell Abnormalities

  • Leukopenia: WBC 3.4 ×10⁹/L is below normal, raising concern for bone marrow dysfunction 1

Preserved Platelet Count

  • Platelets 247 ×10⁹/L are normal, which is important because abnormalities in multiple cell lines would strongly suggest bone marrow failure 1

Diagnostic Interpretation

The combination of severe macrocytic anemia (MCV >115 fL) with leukopenia but preserved platelets most commonly indicates either vitamin B12 deficiency, folate deficiency, or early myelodysplastic syndrome 2. The markedly elevated MCV above 115 fL is particularly characteristic of megaloblastic processes.

Research shows that 58.1% of non-severe aplastic anemia patients present with macrocytic anemia, while most severe aplastic anemia cases show normocytic anemia 2. Your preserved platelet count makes severe aplastic anemia less likely but doesn't exclude it entirely.

The elevated RDW (17.1%) combined with macrocytosis suggests active but ineffective erythropoiesis, which can indicate residual bone marrow function attempting to compensate 2. This pattern is seen in both nutritional deficiencies and myelodysplastic syndromes.

Immediate Next Steps Required

Priority Laboratory Tests

  1. Vitamin B12 level - Most critical given MCV >115 fL
  2. Folate level - Second most common cause of severe macrocytosis
  3. Reticulocyte count - Determines if bone marrow is responding appropriately to anemia 1
  4. Peripheral blood smear - Look for hypersegmented neutrophils (B12/folate deficiency) or dysplastic changes (MDS)
  5. Methylmalonic acid and homocysteine - If B12 is borderline, these confirm true deficiency

Secondary Evaluation

  • Thyroid function tests - Hypothyroidism can cause macrocytic anemia
  • Liver function beyond ALT - Your ALT 31 U/L is normal 3, but need full hepatic panel as liver disease can cause macrocytosis
  • Serum ferritin and transferrin saturation - Rule out concurrent iron deficiency 1

Consider Hematology Referral If:

  • B12 and folate are normal
  • Reticulocyte count is inappropriately low
  • Peripheral smear shows dysplastic features
  • No improvement after 1-2 weeks of vitamin replacement

Clinical Pitfalls to Avoid

Do not assume this is simply "anemia of chronic disease" based on the normal ALT - the degree of macrocytosis (MCV 115.7) is too severe for most chronic conditions and demands specific investigation 1.

Do not delay B12/folate testing - these are reversible causes of severe anemia that can lead to permanent neurological damage if untreated.

Do not ignore the leukopenia - while mild, it suggests this is not isolated red cell pathology and raises concern for bone marrow involvement 1. The guideline emphasizes that abnormalities in two or more cell lines warrant careful evaluation and likely hematology consultation.

Symptomatic Management Considerations

Given hemoglobin of 8 g/dL, assess for:

  • Dyspnea, chest pain, or severe fatigue requiring transfusion
  • Neurological symptoms (paresthesias, ataxia, cognitive changes) suggesting B12 deficiency
  • Signs of bleeding or infection given the cytopenias

If B12 deficiency is confirmed, initiate parenteral B12 replacement immediately - oral replacement may be insufficient for severe deficiency with neurological risk.

References

Guideline

clinical practice guidelines for evaluation of anemia.

Kidney International Supplements, 2008

Research

Updated Reference Intervals for Alanine Aminotransferase in a Metabolically and Histologically Normal Population.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2024

Related Questions

Can you interpret a CBC with total leukocyte count 7.37 ×10³/µL, monocyte count 0.65 ×10³/µL, hemoglobin 10.5 g/dL, mean corpuscular volume 77.7 fL, mean corpuscular hemoglobin 23.8 pg, mean corpuscular hemoglobin concentration 30.7 g/dL, platelet count 102 ×10³/µL, and red‑cell distribution width 16.4%?
Can you interpret my complete blood count (white blood cells 7.7 K/µL, red blood cells 4.64 M/µL, hemoglobin 14.7 g/dL, hematocrit 43.9 %, mean corpuscular volume 94.6 fL, mean corpuscular hemoglobin 31.6 pg, mean corpuscular hemoglobin concentration 33.4 g/dL, red cell distribution width 13.5 %, platelets 301 K/µL, mean platelet volume 9.4 fL, neutrophils 51 %, lymphocytes 33 %, monocytes 8.5 %, eosinophils 6 %, basophils 1.1 %) and advise if any further evaluation is needed?
In a 47-year-old man with low red blood cell count, low hemoglobin, low hematocrit, low mean corpuscular hemoglobin, low mean corpuscular hemoglobin concentration, normal mean corpuscular volume, normal white blood cell count, and isolated low absolute lymphocyte count, what is the most likely diagnosis and what initial workup and management should be pursued?
Are a hematocrit of 46.6%, red blood cell count of 5.14 ×10⁶/µL, and alanine aminotransferase (ALT) of 49 U/L normal or indicative of any pathology?
Based on a complete blood count showing a normal white blood cell count, mildly low hemoglobin (11.6 g/dL) and hematocrit (35.4 %), normal red blood cell count, normal mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration (MCHC), slightly elevated red cell distribution width (RDW) (15.8 %) and mildly high mean platelet volume (MPV) (13.1 fL), what is the interpretation of these results?
What is the recommended workup and treatment for a patient with a positive antinuclear antibody (ANA) and suspected vasculitis?
Can synchronized intermittent mandatory ventilation (SIMV) in volume control mode be used with a speaking valve?
What is the recommended dosing and additional antimicrobial coverage when using ceftazidime and metronidazole?
What is the appropriate treatment for a patient with a strongly positive antinuclear antibody (ANA) indicating possible lupus-related vasculitis?
What intravenous anti‑inflammatory medication is appropriate for a healthy adolescent (approximately 12‑18 years old) requiring short‑term therapy?
Does low blood glucose combined with high blood ketone levels reduce inflammation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.